Omega-3 fish oil shows promise against type 2 diabetes

A recent Brazilian study has revealed that omega-3 fish oil supplementation may help reduce insulin resistance and improve blood sugar control in non-obese subjects with type 2 diabetes. Using Goto-Kakizaki rats, a recognized animal model for non-obese type 2 diabetes, researchers administered fish oil rich in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) over eight weeks. The treated rats exhibited significant improvements in glucose intolerance, insulin sensitivity, inflammatory markers, and lipid profiles, including reductions in total cholesterol, LDL cholesterol, and triglycerides. This research highlights the potential role of inflammation in the development of insulin resistance in non-obese individuals, a subgroup that represents approximately 10% to 20% of the global type 2 diabetes population. Unlike the more common obesity-linked pathways, the biological mechanisms behind insulin resistance in these patients may involve distinct immune and inflammatory processes. The study found that omega-3 supplementation shifted lymphocytes, a type of white blood cell, from a pro-inflammatory to an anti-inflammatory state, suggesting a novel immunomodulatory effect of fish oil in diabetes management. While omega-3 fatty acids have been widely studied for their benefits in obese patients with type 2 diabetes, this study provides new insights into their potential application for non-obese diabetic individuals. The findings underscore the importance of targeting inflammation as a therapeutic strategy beyond weight management. However, as the results are based on preclinical animal models, further clinical trials are necessary to confirm the efficacy and safety of omega-3 supplementation in human patients with non-obese type 2 diabetes. The study opens new avenues for understanding and treating a less recognized form of type 2 diabetes, emphasizing the need for personalized approaches that consider different underlying causes of insulin resistance. If confirmed in humans, omega-3 fish oil could become a valuable adjunct therapy for improving metabolic health in this distinct patient group.